SCHEMBL8798249

SCHEMBL8798249

CCOC(=O)C(CCCNC(=O)OC(C)(C)C)(OC(C)c1cccnc1)C(=O)OCC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.46
GAA P10253 2/20 0.39
NAMPT P43490 2/20 0.39
RAB9A P51151 1/20 0.39
PTPRB P23467 1/20 0.37
IDO1 P14902 2/20 0.37
ADORA2B P29275 1/20 0.37
STING1 Q86WV6 1/20 0.36
MAPK1 P28482 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
NPSR1 Q6W5P4 3/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
MAPT P10636 2/20 0.36
KDM4E B2RXH2 1/20 0.36
POLB P06746 1/20 0.36
FAAH O00519 1/20 0.36
CA12 O43570 2/20 0.35
CA1 P00915 2/20 0.35
CA2 P00918 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8799637 0.82 CYP3A4 (0.49) CYP3A4NAMPTRAB9APTPRBIDO1
SCHEMBL8798754 0.81 CYP3A4 (0.57) CYP3A4NAMPTRAB9APTPRBIDO1
SCHEMBL8798252 0.80 CYP3A4 (0.56) CYP3A4NAMPTPTPRBIDO1FAAH
SCHEMBL8799915 0.76 CA1 (0.45) CYP3A4GAAPTPRBIDO1NPSR1
SCHEMBL8798836 0.76 CYP3A4 (0.56) CYP3A4NAMPTRAB9APTPRBIDO1
SCHEMBL25496745 0.75 CYP3A4 (0.56) CYP3A4GAANAMPTRAB9AIDO1
SCHEMBL29907305 0.75 CYP3A4 (0.56) CYP3A4GAANAMPTRAB9AIDO1
SCHEMBL28975900 0.75 CYP3A4 (0.56) CYP3A4GAANAMPTRAB9AIDO1
SCHEMBL8799761 0.74 CYP3A4 (0.44) CYP3A4NAMPTPTPRBIDO1NPSR1
SCHEMBL8800029 0.73 KEAP1 (0.42) CYP3A4RAB9APTPRBIDO1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0792878-A2 Geminal carboxylic acids and esters thereof, pharmaceutical formulations containing them useful in the treatment of bone dysmetabolism Dompé S.P.A. (IT) 1997-09-03 EP disclosed